Monday, May 29, 2023
DISCLOSURE OF FINANCIAL RELATIONSHIPS
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content
to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial
relationships are thoroughly vetted and mitigated according to RMEI policy.
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts
All of the relevant financial relationships listed for this individual have been mitigated according to RMEI policies.
Planners and Managers
All planners and managers have no relevant financial relationship(s) with ineligible companies.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated
by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions
expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications,
and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own
professional development. The information presented in this activity is not meant to serve as a guideline for patient management.
Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not
be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use,
review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™
Nurses - 0.75 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)
Pharmacists - 0.75 Knowledge-based ACPE (0.075 CEUs)
This activity is intended for clinicians practicing in transplantation, infectious disease, and nephrology.
This activity is meant to improve clinician’s identification of resistant/refractory cytomegalovirus (CMV) and update them on newly approved treatment strategies for resistant/refractory CMV in solid organ transplant (SOT) patients.
CMV is one of the most common opportunistic infections affecting solid organ transplant recipients (SOTRs), conveying higher risks of complications, graft loss, morbidity, and mortality. Treatment options for CMV are limited, have similar mechanisms of action, suffer from cross-resistance, and have serious toxicities. Until recently, no treatment option was available in the resistant/refractory setting. This workshop, developed in collaboration with The Transplantation Society (TTS) and Dr. Camille Kotton, MD, FIDSA, FAST, will take you through a CMV primer and then move on to discuss cases submitted by your peers from transplant centers across the United States.
Upon completion of this activity, participants should be better able to:
DISCLOSURE OF FINANCIAL RELATIONSHIPS
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content
to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial
relationships are thoroughly vetted and mitigated according to RMEI policy.
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts
All of the relevant financial relationships listed for this individual have been mitigated according to RMEI policies.
Planners and Managers
All planners and managers have no relevant financial relationship(s) with ineligible companies.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated
by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions
expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications,
and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own
professional development. The information presented in this activity is not meant to serve as a guideline for patient management.
Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not
be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use,
review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
RMEI Medical Education, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours(s).
RMEI Medical Education, LLC designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number: JA4008290-9999-22-001-H01-P)
Type of Activity: Knowledge
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
In order to receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. A statement of credit will be available to print immediately. You must score 80% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at [email protected].
Users must:
There is no fee to participate.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / CE Released: 9/15/2022
Valid for credit through: 9/14/2023
processing....
Before you begin, please take this brief survey.
